Ascendis Pharma A/S Other Noncurrent Receivables
Ascendis Pharma A/S (ASND) had Other Noncurrent Receivables of EUR 10.87 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes › Receivables
ifrs-full:OtherNoncurrentReceivables · last filed 2026-02-11
- 2025-12-31: Other Noncurrent Receivables 10.87M EUR.
- 2025-09-30: Other Noncurrent Receivables 3.16M EUR.
- 2025-06-30: Other Noncurrent Receivables 2.71M EUR.
- 2025-03-31: Other Noncurrent Receivables 2.66M EUR.
| Period end | Other Noncurrent Receivables |
|---|---|
| 2025-12-31 | 10.87M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 3.16M EUR 6-K · filed 2025-11-12 |
| 2025-06-30 | 2.71M EUR 6-K · filed 2025-08-07 |
| 2025-03-31 | 2.66M EUR 6-K · filed 2025-05-01 |
| 2024-12-31 | 2.32M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 2.20M EUR 6-K · filed 2024-11-14 |
| 2024-06-30 | 2.19M EUR 6-K · filed 2024-09-03 |
| 2024-03-31 | 2.13M EUR 6-K · filed 2024-05-02 |
| 2023-12-31 | 2.13M EUR 20-F · filed 2025-02-12 |
| 2023-09-30 | 2.14M EUR 6-K · filed 2023-11-07 |
| 2023-06-30 | 2.07M EUR 6-K · filed 2023-09-05 |
| 2023-03-31 | 1.98M EUR 6-K · filed 2023-04-27 |
| 2023-01-01 | 1.92M EUR 20-F · filed 2025-02-12 |
| 2022-12-31 | 1.92M EUR 20-F · filed 2024-02-07 |
| 2022-09-30 | 1.90M EUR 6-K · filed 2022-11-02 |
| 2022-06-30 | 1.84M EUR 6-K · filed 2022-08-10 |
| 2022-03-31 | 1.82M EUR 6-K · filed 2022-05-11 |
| 2021-12-31 | 1.81M EUR 20-F · filed 2023-02-16 |
| 2021-03-31 | 1.78M EUR 6-K · filed 2021-05-27 |
| 2020-12-31 | 1.38M EUR 20-F · filed 2022-03-02 |
| 2019-12-31 | 1.46M EUR 20-F · filed 2021-03-10 |